HEMOPHILIA
Clinical trials for HEMOPHILIA explained in plain language.
Never miss a new study
Get alerted when new HEMOPHILIA trials appear
Sign up with your email to follow new studies for HEMOPHILIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly treatment aims to protect hemophilia Patients' joints
Disease control OngoingThis study is checking if a weekly preventative treatment called efanesoctocog alfa can improve joint health in people with moderate or severe Hemophilia A. It will follow about 37 patients in Europe for 12 months, using ultrasound and MRI scans to see if the treatment reduces jo…
Matched conditions: HEMOPHILIA
Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New injection could drastically cut bleeding episodes for hemophilia patients
Disease control OngoingThis study is testing if a new drug called fitusiran, given as an injection, can better prevent bleeding episodes in males aged 12 and older who have severe hemophilia A or B. Participants will first be monitored on their current standard treatment, then switch to fitusiran for a…
Matched conditions: HEMOPHILIA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hemophilia drug aims for Long-Term bleeding control
Disease control OngoingThis study is checking the long-term safety and effectiveness of a drug called fitusiran for people with severe hemophilia A or B. It involves about 281 male participants, aged 12 and older, who have already been in a previous fitusiran trial. The main goal is to see how well the…
Matched conditions: HEMOPHILIA
Phase: PHASE3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Can a new training trick ease the ache of hemophilia knees?
Symptom relief ENROLLING_BY_INVITATIONThis study is testing if a special type of exercise, called blood flow restriction training, can help reduce knee pain and improve daily life for people with hemophilia who have joint damage. Twelve participants will try both the special training and a sham version to see which o…
Matched conditions: HEMOPHILIA
Phase: NA • Sponsor: University Hospital, Bonn • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Major study maps hemophilia care across china
Knowledge-focused OngoingThis study aims to understand the real-world costs, treatment patterns, and patient experiences of living with severe hemophilia in China. It will enroll 500 male patients aged 12 and older to collect data on their care, expenses, and quality of life. The goal is to identify gaps…
Matched conditions: HEMOPHILIA
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC